Literature DB >> 20563295

Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures.

Rajiv Chopra1, Natalia Vykhodtseva, Kullervo Hynynen.   

Abstract

Pulsed ultrasound exposures of brain tissue in the presence of micro-bubble contrast agents have been shown to achieve transient focal disruption of the blood brain barrier without significant damage to surrounding brain tissue. The effects of overall exposure duration on the extent of blood brain barrier disruption was studied in these experiments to determine operating conditions for increasing the amount of therapeutic agents delivered to the brain. Exposures at 1.08 MHz ranging from 0.2 to 0.8 MPa in amplitude were delivered transcranially to the brains of rabbits and rats for durations ranging from 30 to 1200 seconds. The amount of signal enhancement on contrast-enhanced T1-weighted MR images were used to quantify the extent of blood brain barrier disruption and histological evaluation of the exposed regions was performed to evaluate the impact on brain tissue. A subset of four rats underwent weekly exposures for 3 weeks to evaluate the feasibility of repeat sonications to the brain. The results suggest that exposures less than 180 seconds in duration are associated with a low probability of irreversible damage to brain tissue at pressure amplitudes of 0.38 MPa. Although exposures greater than 300 seconds were associated with an increase in the proportion of irreversible damage, this may be acceptable for chemotherapy delivery, where the therapeutic goal is tissue destruction. Repeat exposures to the brain were feasible, but resulted in evidence of focal brain damage in 50% of animals.

Entities:  

Year:  2010        PMID: 20563295      PMCID: PMC2885821          DOI: 10.1021/cn9000445

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  20 in total

Review 1.  Drug delivery to the central nervous system: a review.

Authors:  Ambikanandan Misra; S Ganesh; Aliasgar Shahiwala; Shrenik P Shah
Journal:  J Pharm Pharm Sci       Date:  2003 May-Aug       Impact factor: 2.327

Review 2.  Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain.

Authors:  Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2007-01       Impact factor: 6.648

3.  Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.

Authors:  Manabu Kinoshita; Nathan McDannold; Ferenc A Jolesz; Kullervo Hynynen
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

4.  Microbubble contrast agent with focused ultrasound to create brain lesions at low power levels: MR imaging and histologic study in rabbits.

Authors:  Nathan J McDannold; Natalia I Vykhodtseva; Kullervo Hynynen
Journal:  Radiology       Date:  2006-10       Impact factor: 11.105

5.  Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity.

Authors:  N McDannold; N Vykhodtseva; K Hynynen
Journal:  Phys Med Biol       Date:  2006-01-25       Impact factor: 3.609

Review 6.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

Authors:  R A Kroll; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

7.  Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound.

Authors:  Lisa H Treat; Nathan McDannold; Natalia Vykhodtseva; Yongzhi Zhang; Karen Tam; Kullervo Hynynen
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

8.  Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Authors:  Kullervo Hynynen; Nathan McDannold; Nickolai A Sheikov; Ferenc A Jolesz; Natalia Vykhodtseva
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

9.  Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption.

Authors:  Feng-Yi Yang; Wen-Mei Fu; Rong-Sen Yang; Houng-Chi Liou; Kai-Hsiang Kang; Win-Li Lin
Journal:  Ultrasound Med Biol       Date:  2007-06-11       Impact factor: 2.998

Review 10.  Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.

Authors:  Gabriel A Silva
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more
  44 in total

1.  Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.

Authors:  Natalya Rapoport; Kweon-Ho Nam; Roohi Gupta; Zhongao Gao; Praveena Mohan; Allison Payne; Nick Todd; Xin Liu; Taeho Kim; Jill Shea; Courtney Scaife; Dennis L Parker; Eun-Kee Jeong; Anne M Kennedy
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

Review 2.  Ultrasound enhanced drug delivery to the brain and central nervous system.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

Review 3.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

4.  Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.

Authors:  Muna Aryal; Natalia Vykhodtseva; Yong-Zhi Zhang; Nathan McDannold
Journal:  J Control Release       Date:  2015-02-24       Impact factor: 9.776

Review 5.  Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability.

Authors:  Dallan McMahon; Charissa Poon; Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2019-01-29       Impact factor: 6.648

6.  Focused-ultrasound disruption of the blood-brain barrier using closely-timed short pulses: influence of sonication parameters and injection rate.

Authors:  Meaghan A O'Reilly; Adam C Waspe; Milan Ganguly; Kullervo Hynynen
Journal:  Ultrasound Med Biol       Date:  2011-03-03       Impact factor: 2.998

Review 7.  Advances in acoustic monitoring and control of focused ultrasound-mediated increases in blood-brain barrier permeability.

Authors:  Ryan M Jones; Kullervo Hynynen
Journal:  Br J Radiol       Date:  2019-02-28       Impact factor: 3.039

8.  Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis.

Authors:  Benjamin Marty; Benoit Larrat; Maxime Van Landeghem; Caroline Robic; Philippe Robert; Marc Port; Denis Le Bihan; Mathieu Pernot; Mickael Tanter; Franck Lethimonnier; Sébastien Mériaux
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-18       Impact factor: 6.200

9.  Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.

Authors:  Cherry C Chen; Paul S Sheeran; Shih-Ying Wu; Oluyemi O Olumolade; Paul A Dayton; Elisa E Konofagou
Journal:  J Control Release       Date:  2013-10-02       Impact factor: 9.776

Review 10.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.